Atlas Trials

Galantamine for Cognitive Deficits in Schizophrenia

Clinical trial NCT00463879 · COMPLETED

Trial details

NCT number
NCT00463879
Sponsor
Yale University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2005-09-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.